Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
07:00am, Friday, 26'th Mar 2021
MINNEAPOLIS, March 26, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award
Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test
07:00am, Tuesday, 23'rd Mar 2021
MINNEAPOLIS, March 23, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro diag
Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing Facility.
07:00am, Monday, 15'th Mar 2021
MINNEAPOLIS, March 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagn
NEW YORK, March 10, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX / NASDAQ: RNLX), announced today it has been named
Bio-Techne Scoops Up Genetics And Oncology-Focused Diagnostics Firm
06:37am, Thursday, 04'th Mar 2021
Bio-Techne Corp (NASDAQ: TECH) has agreed to acquire Asuragen Inc, a provider of genetic carrier screening and oncology testing kits. The deal value includes an initial consideration of $215 million
Bio-Techne to Acquire Asuragen
04:45pm, Wednesday, 03'rd Mar 2021
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research an
Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
07:30am, Monday, 08'th Feb 2021
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE:RENX / NASDAQ: RNLX), and manufacturing partner Bio-Techne C
Bio-Techne Corporation (TECH) CEO Charles Kummeth on Q2 2021 Results - Earnings Call Transcript
02:56pm, Tuesday, 02'nd Feb 2021
Bio-Techne Corporation (TECH) CEO Charles Kummeth on Q2 2021 Results - Earnings Call Transcript
Techne (TECH) Q2 Earnings and Revenues Top Estimates
08:20am, Tuesday, 02'nd Feb 2021
Techne (TECH) delivered earnings and revenue surprises of 19.12% and 9.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Bio-Techne: Q2 Earnings Insights
07:08am, Tuesday, 02'nd Feb 2021
Shares of Bio-Techne (NASDAQ:TECH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 50.00% year over year to $1.62, which beat the estimate of
Bio-Techne Declares Dividend
06:30am, Tuesday, 02'nd Feb 2021
MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31
Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development
07:00am, Wednesday, 02'nd Dec 2020
MINNEAPOLIS, Dec. 2, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the cli
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2021 Results - Earnings Call Transcript
03:54am, Sunday, 08'th Nov 2020
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2021 Results - Earnings Call Transcript
Bio-Techne Releases First Quarter Fiscal 2021 Results
06:30am, Thursday, 05'th Nov 2020
MINNEAPOLIS, Nov. 5, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2020. First Quarter FY2021 Snapshot First
